Dapsone (daspone) NDC 69238-1627

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-1627Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-1627Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69238-1627-6	69238162706	1 BOTTLE, PUMP in 1 CARTON (69238-1627-6) / 60 g in 1 BOTTLE, PUMPMarketed from Jun 2, 2023
69238-1627-9	69238162709	1 BOTTLE, PUMP in 1 CARTON (69238-1627-9) / 90 g in 1 BOTTLE, PUMPMarketed from Jun 2, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dapsone
Generic name (nonproprietary): daspone
Active ingredients: Dapsone — 75 mg/g
Dosage form: Gel
Route: Topical
Labeler: Amneal Pharmaceuticals NY LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212701
Marketing start: Jun 2, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Sulfones (Chemical structure)
Identifiers: Product ID 69238-1627_0622cdcc-1196-4a2f-8c85-6f34f0f97f9dSPL ID 0622cdcc-1196-4a2f-8c85-6f34f0f97f9dSPL set ID fba0b181-077a-4667-bde1-cf9592f120c2RxCUI 1741905UNII 8W5C518302
Pharmacologic class: Sulfone

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238162706 followed by a unit qualifier and the quantity

Package 69238-1627-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 31, 2023.

Indications (excerpt from the label)

Dapsone gel, 7.5%, is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Dapsone gel, 7.5%, is a sulfone indicated for the topical treatment of acne vulgaris in patients 9 years of age and older (1) .

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)